research use only

GDC-0575 Chk inhibitor

Cat.No.S8526

GDC-0575 is a potent and selective CHK1 inhibitor with an IC50 of 1.2 nM.
GDC-0575 Chk inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 378.27

Jump to

Quality Control

Batch: Purity: 99.81%
99.81

Solubility

In vitro
Batch:

DMSO : 75 mg/mL (198.27 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 10 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 378.27 Formula

C16H20BrN5O

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 1196541-47-5 -- Storage of Stock Solutions

Synonyms ARRY-575, RG7741 Smiles C1CC(CN(C1)C2=C3C(=CNC3=NC=C2Br)NC(=O)C4CC4)N

Mechanism of Action

Targets/IC50/Ki
Chk1
(Cell-free assay)
1.2 nM
In vitro

GDC-0575 enhances the cytotoxicity of Cytarabine (AraC) in vitro.

In vivo

GDC-0575 is a highly-selective oral small-molecule Chk1 inhibitor that results in tumor shrinkage and growth delay in xenograft models.

References

Applications

Methods Biomarkers Images PMID
Western blot pCHK1 / pRPA2 / RPA2 / RRM2 / γH2AX / α-tub pCHK2 / pCHK1 / p53 / pRPA2 / RPA2 / RRM2 / γH2AX / α-tub tPARP / cPARP / γH2AX / Tubulin
S8526-WB-1
31044505
Growth inhibition assay tumor volume
S8526-Growth-inhibition-assay-1
31044505
IHC H&E staining / PCNA expression H&E staining Small intestine / Colon
S8526-IHC-1
33897258
Immunofluorescence F4/80 / iNOS F4/80 / iNOS F4/80 / CCR2 F4/80 / CCR2
S8526-IF-1
33897258

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01564251 Completed
Lymphoma Solid Tumor
Genentech Inc.
March 23 2012 Phase 1

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map